HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-08-02FDA Approved: BIKTARVY — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for BIKTARVY (bictegravir/emtricitabine/tenofovir alafenamide) submitted by Gilead Sciences, Inc…
-
CLINICAL_TRIALS trial_result · 2019-08-02Clinical Trial Update: Effects of Losartan and Antiretroviral Regimen Containing Raltegravir in Fibrosis Inflammation Mediators, Cardiovascular Risk and Neurocognitive Disorders in HIV Infected Patients Previously Effectively Treated [Phase 4]
Phase 4 trial update examining the effects of losartan combined with an antiretroviral regimen containing raltegravir on fibrosis, inflammat…
-
FDA approval · 2019-07-26FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Laurus Labs Limited)
FDA approved Laurus Labs Limited's generic emtricitabine and tenofovir disoproxil fumarate tablets under an Original Application (ANDA).
-
FDA approval · 2019-07-25FDA Approved: ABACAVIR AND LAMIVUDINE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application from Cipla USA Inc. for abacavir and lamivudine (abacavir/lamivudine).
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Neurocognitive Function Improvement After Switching From Efavirenz to Rilpivirine [Phase 4]
Phase 4 trial update exploring neurocognitive function after switching from Efavirenz to Rilpivirine in people with HIV-1 infection and neur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: Integrated Care Centers to Improve HIV Outcomes in Vulnerable Indian Populations [NA]
Completed clinical trial evaluating integrated care centers to improve HIV outcomes in vulnerable Indian populations; results posted in 2019…
-
CLINICAL_TRIALS trial_result · 2019-07-15Clinical Trial Update: Activity of MK-8504 in Anti-retroviral-naïve, Human Immunodeficiency Virus 1 (HIV-1) Infected Participants (MK-8504-002) [Phase 1]
Phase 1 clinical trial update for MK-8504 in ART-naïve HIV-1 infected participants; study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-11Clinical Trial Update: BK Virus in Salivary Gland Disease: Treating the Potential Etiologic Agent [Phase 3]
Phase 3 trial update investigating BK virus as a potential etiologic agent for salivary gland disease with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2019-07-11Clinical Trial Update: VRC 605: Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered Intravenously or Subcutaneously to Healthy Adults [Phase 1]
Phase 1 safety and pharmacokinetics study of the human monoclonal antibody VRC07-523LS (VRC-HIVMAB075-00-AB) for HIV prevention, with result…
-
FDA approval · 2019-07-10FDA Approved: ETRAVIRINE — Supplemental Application (Patriot Pharmaceuticals)
FDA approved a supplemental application for etravirine submitted by Patriot Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Lipopeptide Immunisation With GTU-multiHIV Trial [Phase 2]
Phase 2 clinical trial update for GTU-multiHIV lipopeptide immunisation in HIV-1 infection has been completed.
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: Safety and Pharmacokinetic Study of HIV Prophylaxis Using Antiretroviral Intravaginal Rings in Healthy Women [EARLY_Phase 1]
Early-phase safety and pharmacokinetic study of antiretroviral intravaginal rings for HIV prophylaxis in healthy women has completed with re…
-
FDA approval · 2019-07-01FDA Approved: TRUVADA — Supplemental Application (Gilead Sciences, Inc)
The FDA approved a supplemental application for TRUVADA (emtricitabine/tenofovir disoproxil fumarate) submitted by Gilead Sciences. The appr…
-
FDA approval · 2019-07-01FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Emtricitabine and Tenofovir Disoproxil Fumarate from Mylan Pharmaceuticals Inc., authorizing the…
-
FDA approval · 2019-07-01FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's supplemental application for Emtricitabine and Tenofovir Disoproxil Fumarate.
-
FDA approval · 2019-07-01FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's supplemental application for the generic fixed-dose combination emtricitabine and tenofovir disoproxil fumarate for the …
-
FDA approval · 2019-07-01FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
The FDA approved a supplemental application for Emtricitabine and Tenofovir Disoproxil Fumarate from Quallent Pharmaceuticals Health LLC. Th…
-
CLINICAL_TRIALS research · 2019-06-25Clinical Trial Update: Evaluating Accuracy, Impact, and Operational Challenges of GeneXpert Use for TB Case Finding Among HIV-infected Persons [Phase 4]
A Phase 4 clinical trial assessing the accuracy, impact, and operational challenges of GeneXpert use for tuberculosis case finding among peo…
-
FDA approval · 2019-06-18FDA Approved: BIKTARVY — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for BIKTARVY from Gilead Sciences.
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: Combination Vaccination Before HIV Treatment Interruption [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigating a combination vaccination strategy administered before HIV treatment interruption; completed with r…
-
CLINICAL_TRIALS trial_result · 2019-06-13Clinical Trial Update: Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults [Phase 3]
Phase 3 study evaluating switching virologically suppressed HIV-1-infected adults from their current antiretroviral regimen to long-acting c…
-
CLINICAL_TRIALS withdrawal · 2019-06-13Clinical Trial Update: A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C [Phase 4]
Phase 4 trial of simeprevir and sofosbuvir for HIV/Hepatitis C was withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: Lopinavir/r/ Lamivudine/ Abacavir as an Easy to Use Paediatric Formulation [Phase 1, Phase 2]
A pediatric formulation of lopinavir/ritonavir with lamivudine and abacavir is being studied in Phase 1/2 trials, focusing on ease of use fo…
-
CLINICAL_TRIALS research · 2019-06-04Clinical Trial Update: Harnessing the Power of Text Messaging to Invigorate AMSM HIV Preventive Behavior [NA]
A completed clinical trial examining text messaging to improve HIV preventive behaviors among adolescent men who have sex with men (AMSM). R…
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: A Randomized Controlled Trial of HIV Testing and Linkage to Care at Community Corrections [NA]
A completed randomized trial assessing HIV testing and linkage to care within community corrections settings; results posted in 2019.